|
業務類別
|
Medical Devices |
|
業務概覽
|
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets. |
| 公司地址
| 4721 Emperor Boulevard, Suite 100, Durham, NC, USA, 27703 |
| 電話號碼
| +1 919 474-6700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.bioventus.com |
| 員工數量
| 930 |
| Mr. Robert E. Claypoole |
Director, President and Chief Executive Officer |
美元 780.33K |
22/04/2025 |
| Mr. Anthony D’Adamio |
Senior Vice President and General Counsel |
美元 447.77K |
22/04/2025 |
| Ms. Katrina Church |
Senior Vice President and Chief Compliance Officer |
-- |
22/04/2025 |
| Mr. Mark Leonard Singleton |
Senior Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 473.83K |
22/04/2025 |
|
|
| Mr. Robert E. Claypoole |
Director, President and Chief Executive Officer |
22/04/2025 |
| Mr. John A. Bartholdson |
Independent Director |
22/04/2025 |
| Mr. Guido J. Neels |
Independent Director |
22/04/2025 |
| Mr. Guy P. Nohra |
Independent Director |
22/04/2025 |
| Mr. Martin P. Sutter |
Independent Director |
22/04/2025 |
| Dr. Ajay Dhankhar |
Director |
17/11/2025 |
| Mr. William A. Hawkins, III |
Chairman of the Board |
22/04/2025 |
| Ms. Susan M. Stalnecker |
Independent Director |
22/04/2025 |
| Mr. Patrick J. Beyer |
Independent Director |
22/04/2025 |
| Ms. Mary Katherine Ladone |
Independent Director |
22/04/2025 |
| Mr. Philip G. Cowdy |
Independent Director |
22/04/2025 |
| Dr. Michelle McMurry-Heath, PhD |
Independent Director |
22/04/2025 |
|
|
|
|
